Cheng Chunwei, Hua Juan, Tan Jun, Qian Wei, Zhang Lei, Hou Xiaohua
Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.
Department of Cardiology, The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University, Wuhan, Hubei 430015, P.R. China.
Exp Ther Med. 2019 Jul;18(1):278-288. doi: 10.3892/etm.2019.7541. Epub 2019 May 3.
Inflammatory bowel diseases (IBDs), including ulcerative colitis (UC) and Crohn's disease (CD), are chronic inflammatory disorders caused by genetic influences, the immune system and environmental factors. However, the underlying pathogenesis of IBDs and the pivotal molecular interactions remain to be fully elucidated. The aim of the present study was to identify genetic signatures in patients with IBDs and elucidate the potential molecular mechanisms underlying IBD subtypes. The gene expression profiles of the GSE75214 datasets were obtained from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were identified in UC and CD patients compared with controls using the GEO2R tool. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses of DEGs were performed using DAVID. Furthermore, protein-protein interaction (PPI) networks of the DEGs were constructed using Cytoscape software. Subsequently, significant modules were selected and the hub genes were identified. In the GO and KEGG pathway analysis, the top enriched pathways in UC and CD included infection, rheumatoid arthritis, complement and coagulation cascades, PI3K/Akt signaling pathway and osteoclast differentiation. In addition, the GO terms in the category biological process significantly enriched by these genes were inflammatory response, immune response, leukocyte migration, cell adhesion, response to molecules of bacterial origin and extracellular matrix (ECM) organization. However, several other biological processes (GO terms) and pathways (e.g., 'chemotaxis', 'collagen catabolic process' and 'ECM-receptor interaction') exhibited significant differences between the two subtypes of IBD. The top 10 hub genes were identified from the PPI network using respective DEGs. Of note, the hub genes G protein subunit gamma 11 (GNG11), G protein subunit beta 4 (GNB4), Angiotensinogen (AGT), Phosphoinositide-3-kinase regulatory subunit 3 (PIK3R3) and C-C motif chemokine receptor 7 (CCR7) are disease-specific and may be used as biomarkers for differentiating UC from CD. Furthermore, module analysis further confirmed that common significant pathways involved in the pathogenesis of IBD subtypes were associated with chemokine-induced inflammation, innate immunity, adapted immunity and infectious microbes. In conclusion, the present study identified DEGs, key target genes, functional pathways and enrichment analysis of IBDs, enhancing the understanding of the pathogenesis of IBDs and also advancing the clarification of the underlying molecular mechanisms of UC and CD. Furthermore, these results may provide potential molecular targets and diagnostic biomarkers for UC and CD.
炎症性肠病(IBD),包括溃疡性结肠炎(UC)和克罗恩病(CD),是由遗传影响、免疫系统和环境因素引起的慢性炎症性疾病。然而,IBD的潜在发病机制和关键分子相互作用仍有待充分阐明。本研究的目的是识别IBD患者的基因特征,并阐明IBD各亚型潜在的分子机制。从基因表达综合数据库获取GSE75214数据集的基因表达谱。使用GEO2R工具在UC和CD患者与对照中识别差异表达基因(DEG)。使用DAVID对DEG进行基因本体(GO)和京都基因与基因组百科全书(KEGG)通路分析。此外,使用Cytoscape软件构建DEG的蛋白质-蛋白质相互作用(PPI)网络。随后,选择显著模块并识别枢纽基因。在GO和KEGG通路分析中,UC和CD中富集程度最高的通路包括感染、类风湿关节炎、补体和凝血级联反应、PI3K/Akt信号通路和破骨细胞分化。此外,这些基因在生物学过程类别中显著富集的GO术语包括炎症反应、免疫反应、白细胞迁移、细胞黏附、对细菌来源分子的反应和细胞外基质(ECM)组织。然而,其他一些生物学过程(GO术语)和通路(如“趋化性”、“胶原蛋白分解代谢过程”和“ECM-受体相互作用”)在IBD的两种亚型之间表现出显著差异。使用各自的DEG从PPI网络中识别出前10个枢纽基因。值得注意的是,枢纽基因G蛋白亚基γ11(GNG11)、G蛋白亚基β4(GNB4)、血管紧张素原(AGT)、磷脂酰肌醇-3-激酶调节亚基3(PIK3R3)和C-C基序趋化因子受体7(CCR7)是疾病特异性的,可作为区分UC和CD的生物标志物。此外,模块分析进一步证实,IBD亚型发病机制中涉及的常见显著通路与趋化因子诱导的炎症、固有免疫适应免疫和感染性微生物有关。总之,本研究识别了IBD的DEG、关键靶基因、功能通路并进行了富集分析,加深了对IBD发病机制的理解,也推进了对UC和CD潜在分子机制的阐明。此外,这些结果可能为UC和CD提供潜在的分子靶点和诊断生物标志物。